Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.36% |
| Sep 30, 2025 | -26.21% |
| Jun 30, 2025 | -16.42% |
| Mar 31, 2025 | 27.93% |
| Dec 31, 2024 | -6.26% |
| Sep 30, 2024 | -29.58% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -8.88% |
| Dec 31, 2023 | -29.22% |
| Sep 30, 2023 | -5.61% |
| Jun 30, 2023 | -55.78% |
| Mar 31, 2023 | -28.44% |
| Dec 31, 2022 | -60.79% |
| Sep 30, 2022 | 21.22% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | -35.15% |
| Dec 31, 2021 | -12.20% |
| Sep 30, 2021 | 26.14% |
| Jun 30, 2021 | -17.22% |
| Mar 31, 2021 | 4.47% |